Gastroenterology clinical trials recruiting in California

115 recruiting gastroenterology trials match in California. Showing 20.

• A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)Recruiting

  Phase 3 · 89bio, Inc. · Canoga Park, California

• A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's DiseaseRecruiting

  Phase 2 · Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company) · Lancaster, California

• A Study to Investigate Abdominal Symptoms With Camlipixant Compared With Placebo in Adults With Irritable Bowel Syndrome - Diarrhea (IBS-D) and Irritable Bowel Syndrome - Mixed (IBS-M)Recruiting

  Phase 2 · GlaxoSmithKline · Anaheim, California

• Congenital Muscle Disease Study of Patient and Family Reported Medical InformationRecruiting

  N/A · Cure CMD · Lakewood, California

• R-3750 in Patients With Mild to Moderate Ulcerative ColitisRecruiting

  Phase 1 · Rise Therapeutics LLC · Valencia, California

• Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bowel Syndrome With Diarrhea in ChildrenRecruiting

  Phase 2 · AbbVie · Hot Springs, Arkansas

• A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)Recruiting

  Phase 2 · Genentech, Inc. · Lancaster, California

• A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)Recruiting

  Phase 3 · Takeda · Oklahoma City, Oklahoma

• A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative ColitisRecruiting

  Phase 2 · Pfizer · Garden Grove, California

• A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASHRecruiting

  Phase 3 · GlaxoSmithKline · Arcadia, California

• Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's DiseaseRecruiting

  Phase 2 · Abivax S.A. · Murrieta, California

• A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASHRecruiting

  Phase 2 · GlaxoSmithKline · Fresno, California

• A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's DiseaseRecruiting

  Phase 2 / Phase 3 · Janssen Research & Development, LLC · Anaheim, California

• Effects of Pomegranate Juice on Ulcerative ColitisRecruiting

  N/A · University of California, Los Angeles · Los Angeles, California

• A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and FibrosisRecruiting

  Phase 3 · Akero Therapeutics, Inc · Coronado, California

• Bicalutamide Therapy in Young Women With NAFLD and PCOSRecruiting

  Phase 1 · University of California, San Francisco · San Francisco, California

• A Phase 2a Study of ALN-PNP With and Without a GLP1R Agonist in Adult Patients With Homozygous PNPLA3-Related MASLDRecruiting

  Phase 2 · Regeneron Pharmaceuticals · Coronado, California

• Implementing Food Referrals for Equity and Sustained HealthRecruiting

  Phase 2 · University of California, San Diego · San Diego, California

• An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative ColitisRecruiting

  N/A · Pfizer · La Jolla, California

• A Study of Efimosfermin Alfa in Adults With Hepatic ImpairmentRecruiting

  Phase 1 · GlaxoSmithKline · Rialto, California

Source: ClinicalTrials.gov. Recruitment status changes often — confirm on each study page.